CPHI Shenzhen 2026 Recap: Three Days in Hall 7 with Copper Peptides and Efficacy Peptides
September 16–18, 2026 · Shenzhen Convention & Exhibition Center (Futian) · Hall 7, booth 7C31-B3
CPHI Shenzhen 2026 ran from September 16 to 18 at the Shenzhen Convention & Exhibition Center (Futian), and the three days produced a clear picture of what formulation and sourcing teams in the region are working on. Hall 7 drew a steady flow of professional visitors, with particular attention on medical aesthetics and efficacy ingredients.
The PEP-SYN booth displayed a solution sample of Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5) alongside a wider efficacy peptide portfolio, while interest on the peptide API side centered on Tirzepatide, Retatrutide and custom synthesis.
Conversations rarely stopped at price. Specification, content basis, COA coverage, sample handling and long-term supply shaped most of the meetings — this recap covers what was shown, what buyers asked for, and how the portfolio is being extended.
1. Three days in Hall 7: how the floor looked
Hall 7 hosted a compact group of upstream suppliers and formulators, and the geography of the hall shaped the traffic. The Medical Aesthetics & Efficacy Debut Zone brought six companies into one open area, which made comparison easier for visitors and kept a steady stream of professional buyers moving through the same aisle.
That audience arrived with specific briefs rather than general curiosity. Formulation teams came with an ingredient list to fill; brand owners came with a launch timeline; trading and sourcing managers came with a qualification file to complete. The result was a floor where technical documentation mattered as much as the sample itself — a pattern that repeated across all three days and across most of the categories on display.
2. Copper peptides at the booth: Tripeptide-1 copper solution samples
The most-requested item at the booth was a solution sample of Copper Tripeptide-1, widely known in the industry as GHK-Cu (CAS 89030-95-5). Displaying the material in solution form made the discussion concrete: visitors could see the characteristic blue of the copper complex and ask directly about concentration, storage and handling.
Questions followed a recognizable order. First the specification — assay, copper content and the basis on which content is calculated. Then the paperwork — which items a COA covers, whether method details can be shared, and how batch records are kept. Sample quantities, lead time for repeat batches and long-term supply continuity came next. For buyers, the practical test was whether a supplier can answer all three groups of questions in one conversation, because that is what a qualification file requires.
3. Copper Tripeptide-1 and Copper Tripeptide-3: two names buyers ask about
Copper peptide inquiries split into two product lines, and the naming matters when specifications are compared.
Supplied as a cosmetic raw material and commonly used in skin-conditioning formulations and appearance-of-repair oriented product concepts. The copper complex gives the finished formula its recognizable color, so storage and compatibility are part of the sourcing conversation.
Listed in Chinese as 丙氨酰-组氨酰-赖氨酸铜. A distinct molecule from Copper Tripeptide-1, commonly formulated for scalp-care and appearance-focused applications. The two are not interchangeable at the bench: content requirements, solubility behavior and compatibility with chelating or strongly reducing systems differ, so each should be qualified on its own specification sheet.
Practical note for qualification files: confirm the exact INCI / material name, salt form and content basis before comparing two copper peptide quotations.
4. Peptide API and custom synthesis: Tirzepatide, Retatrutide and CDMO inquiries
Alongside cosmetic materials, the booth received a steady line of peptide API and development inquiries. Tirzepatide and Retatrutide were the two names visitors raised most often, usually in the context of supply capability, documentation and the ability to support a development program rather than a single order.
Custom synthesis questions followed a development path: define the sequence, purity target, salt form and scale; review feasibility and quotation; produce a small trial or pilot batch; agree on analytical methods and documentation; then scale up once the specification is fixed. Buyers evaluating a CDMO partner tend to look at three things at this stage — whether the analytical package is complete, whether batch-to-batch consistency can be demonstrated, and whether the supplier stays engaged after the first shipment. Those are the points where a booth conversation turns into a qualification process.
5. The efficacy peptide portfolio shown at the booth
Nine materials carried the efficacy peptide line at CPHI Shenzhen 2026. Each is listed with the formulation direction it is commonly used in; none of these descriptions is a finished-product claim.
6. Closing the show: quality, documentation and long-term supply
Three days of conversations left a consistent impression. Buyers were less interested in a catalog than in the parts of supply that decide whether a project ships: consistent quality across batches, complete test documentation, sample-to-bulk continuity, and the flexibility to customise.
That is also where the portfolio is heading. Copper peptides, efficacy peptides, peptide raw materials and custom synthesis services will continue to be extended, with documentation built to match the qualification checklists that brand owners and formulators actually use. Thank you to every customer and partner who visited the booth during CPHI Shenzhen 2026 — the follow-up conversations are already under way.
FAQ
Send your requirement to Rocky at +86 187 5054 6777 or through https://www.pep-syn.com. Requests are quoted with the specification sheet for the grade you need; COA documents accompany each batch, and sample quantities are available for formulation trials before a bulk order is placed.
It starts with a scope review — sequence, purity target, salt form and scale — followed by a feasibility assessment and quotation. A small trial or pilot batch is produced first, analytical methods and documentation are agreed on that batch, and scale-up proceeds once the specification is fixed.
Repeat batches are supplied against the agreed specification, with a COA for each lot, retention samples and the packaging and shipping documents required for import. Buyers who work from a qualification checklist can have those items aligned before the first bulk order, so incoming inspection follows a fixed reference.
References
- CPHI Shenzhen 2026, September 16–18, 2026, Shenzhen Convention & Exhibition Center (Futian), Hall 7 (organized by Informa Markets).
- Copper Tripeptide-1 (GHK-Cu), CAS 89030-95-5.
- Product data, specification sheets and quotations: Rocky, +86 187 5054 6777 or https://www.pep-syn.com.
Working on a copper peptide or efficacy peptide brief after the show?
Contact Rocky at +86 187 5054 6777 or through https://www.pep-syn.com to request product data, specification sheets, samples and quotations.
About Xiamen PEP-SYN Biotech Co., Ltd
Based in Xiamen, Fujian, China, PEP-SYN specializes in peptide R&D and supply, serving pharmaceutical, research and industrial clients worldwide. All products are intended for research and industrial use only.
📞 Contact: Rocky +86 187 5054 6777
🌐 Website: www.pep-syn.com
📍 Address: 3F, No. 603 Hengtian Road, North Station Business Center, Jimei District, Xiamen, Fujian, China
The application directions listed above are common raw-material uses and do not constitute finished-product efficacy claims. This content is for industry communication only and does not constitute medical advice.
